Abstract 18093: Ambulatory Rhythm Monitoring After Transcatheter Aortic Valve Replacement: A Database Observational Study Using TriNetX Through May 2026
Abstract
Background: Conduction abnormalities are common complications following transcatheter aortic valve replacement (TAVR). Real-world utilization of ambulatory rhythm monitoring after TAVR and its association with heart block detection needing pacemaker or ICD implantation remain poorly characterized. We evaluate ambulatory rhythm monitoring practices post-TAVR using a large multicenter electronic health record database. Methods: Using the TriNetX database through May 31, 2026, we identified adults undergoing TAVR who survived to discharge and had ≥12 months of prior healthcare data. Patients with prior pacemakers, ICDs, implantable loop recorders, or pre-existing high-grade atrioventricular block were excluded. We characterized post-TAVR ambulatory rhythm monitoring utilization and assessed rates of permanent pacemaker/ICD implantation within 30 days and conduction abnormality detection within 30-90 days. Results: Among 42,398 adults undergoing TAVR who met eligibility criteria, ambulatory rhythm monitoring was used in a minority of patients. The most commonly utilized modalities were mobile cardiac telemetry (9.4%, n=3,971), patient-activated event monitors (8.7%, n=3,697), and 8-14-day patch monitors (7.8%, n=3,148), followed by 24-48-hour Holter monitors (6.7%, n=2,642) and extended (>48-hour-7-day) patch monitors (4.0%, n=1,614). Implantable loop recorders were used least frequently (1.5%, n=628).Within 30 days of TAVR, permanent pacemaker or ICD implantation occurred in 7.2% of patients monitored with 24-48-hour Holter devices, 6.7% with extended patch monitors, 5.4% with event monitors, 5.3% with 8-14-day patch monitors, 4.3% with mobile cardiac telemetry, and 4.2% with implantable loop recorders. Documented conduction abnormalities within 30-90 days post-TAVR were most frequently identified among implantable loop recorder recipients (42.1%), followed by extended patch monitors (39.6%), 24-48-hour Holters (39.2%), event monitors (37.0%), 8-14-day patch monitors (36.0%), and mobile cardiac telemetry (28.8%). Conclusions: Ambulatory rhythm monitoring after TAVR remains underutilized despite the high burden of post-procedural conduction disturbances. More intensive monitoring, particularly implantable loop recorders and extended patch monitors, was associated with greater detection of clinically significant abnormalities. These findings demonstrate substantial variability in post-TAVR surveillance and support further study to define optimal monitoring strategies for early arrhythmia and conduction disease detection.